Suppr超能文献

自身免疫性糖尿病中免疫调节性T细胞的早期缺陷

Early defect of immunoregulatory T cells in autoimmune diabetes.

作者信息

Gombert J M, Herbelin A, Tancrède-Bohin E, Dy M, Chatenoud L, Carnaud C, Bach J F

机构信息

INSERM U.25, hôpital Necker, Paris, France.

出版信息

C R Acad Sci III. 1996 Feb;319(2):125-9.

PMID:8680958
Abstract

A potential immunoregulatory function has recently been attributed to the discrete subset of major histocompatibility complex (MHC) class I-restricted TCR-alpha beta mature thymocytes expressing an unusual V beta 8-biased T cell receptor repertoire. This T cell subset which also selectively express the CD44 marker is the main IL-4 producer in the thymus. Nonobese diabetic (NOD) mice were found to have a marked deficit in the number and functional capacity of CD44+ TCR-alpha beta+ thymocytes from as early as 3 weeks of age. The deficiency in IL-4 production was completely corrected after incubation with interleukin-7 (IL-7), a selective growth factor for CD44+ TCR-alpha beta+ mature thymocytes. This abnormality in T cell differentiation could explain the Th2 functional deficiency that may be a key element in the emergence of Th1-driven autoimmune disease in NOD mice.

摘要

最近,一种潜在的免疫调节功能被归因于主要组织相容性复合体(MHC)I类限制性TCR-αβ成熟胸腺细胞的离散亚群,该亚群表达异常的Vβ8偏向性T细胞受体库。这个T细胞亚群还选择性表达CD44标志物,是胸腺中主要的IL-4产生者。发现非肥胖糖尿病(NOD)小鼠早在3周龄时,CD44+ TCR-αβ+胸腺细胞的数量和功能能力就有明显缺陷。用白细胞介素-7(IL-7)孵育后,IL-4产生的缺陷完全得到纠正,IL-7是CD44+ TCR-αβ+成熟胸腺细胞的选择性生长因子。T细胞分化的这种异常可以解释Th2功能缺陷,这可能是NOD小鼠中Th1驱动的自身免疫性疾病出现的关键因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验